COSMOS Pharmaceutical Corporation

TSE:3349.T

7358 (JPY) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) JPY.

2023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q12013 Q42013 Q32013 Q22013 Q12012 Q42012 Q32012 Q22012 Q12011 Q42011 Q32011 Q22011 Q12010 Q42010 Q32010 Q22010 Q12009 Q42009 Q32009 Q22009 Q12008 Q42008 Q32008 Q2
Revenue 249,678238,881234,777241,653221,395202,286197,894206,122196,529187,747181,729189,409184,727177,522175,014189,161191,526167,608160,769164,500160,650152,115144,838153,534147,228139,936132,109138,726132,165123,523120,466126,578119,470111,225106,244110,334105,525101,71496,473104,75499,74991,55186,76993,75688,08681,35577,64682,22676,29569,11165,08268,53363,46558,18756,07159,45153,84249,73350,26451,54748,56544,49141,575
Cost of Revenue 201,036192,149188,858194,640176,986161,190156,974163,829156,534150,488145,524151,420148,445142,317139,628150,923154,768133,967129,230131,454128,692122,266115,521122,874117,703112,677106,277111,024106,55698,76996,228101,13596,24089,98685,30588,88984,64182,77977,29085,68182,06574,44169,25175,51171,55166,52262,92966,52562,15556,19352,44855,23951,13947,23245,36547,93543,19640,37640,06541,14838,76135,65232,941
Gross Profit 48,64246,73245,91947,01344,40941,09640,92042,29339,99537,25936,20537,98936,28235,20535,38638,23836,75833,64131,53933,04631,95829,84929,31730,66029,52527,25925,83227,70225,60924,75424,23825,44323,23021,23920,93921,44520,88418,93519,18319,07317,68417,11017,51818,24516,53514,83314,71715,70114,14012,91812,63413,29412,32610,95510,70611,51610,6469,35710,19910,3999,8048,8398,634
Gross Profit Ratio 0.1950.1960.1960.1950.2010.2030.2070.2050.2040.1980.1990.2010.1960.1980.2020.2020.1920.2010.1960.2010.1990.1960.2020.20.2010.1950.1960.20.1940.20.2010.2010.1940.1910.1970.1940.1980.1860.1990.1820.1770.1870.2020.1950.1880.1820.190.1910.1850.1870.1940.1940.1940.1880.1910.1940.1980.1880.2030.2020.2020.1990.208
Reseach & Development Expenses 000000000000000000000000000000000000000000000000000000000000000
General & Administrative Expenses 0000128000127000129000127000128000129000118000117000116000119000127000000000000000000
Selling & Marketing Expenses 00001,6480001,6320002,7840004,2660003,7710001,8360001,8150001,6880001,7810001,6450001,297000000000000000000
SG&A 40,87938,83139,07238,02220,66534,31534,43433,39318,20130,34129,78229,43229,14727,48727,74827,58214,55626,17226,59726,02213,25024,15123,98523,66411,66721,77221,79821,44311,03719,26019,15818,6429,24216,96816,78416,4489,02315,44714,91514,7109,01913,16213,33912,9978,49811,48411,3170000000000000000
Other Expenses 0672807715735710789726863687771745839598694610776624637509857491614559637575702601620577677492535492511505138710424343396376400266316250348298384272291213286227290233343307233210209171244
Operating Expenses 40,87938,83139,07238,02236,44734,31534,43433,39332,09630,34129,78229,43229,14727,48727,74827,58227,09926,17226,59726,02225,20824,15123,98523,66422,55521,77221,79821,44320,74619,26019,15818,64218,00516,96816,78416,44815,92115,44714,91514,71014,35113,16213,33912,99712,66711,48411,31710,78810,7519,8339,6799,3949,4758,7038,6888,5948,1897,9838,0248,1247,8187,7457,567
Operating Income 7,7637,9016,8468,9907,9616,7826,4858,9007,8996,9186,4238,5567,1377,7187,63710,6559,6607,4694,9427,0236,7505,6985,3326,9956,9715,4864,0346,2584,8635,4945,0816,7995,2264,2714,1564,9954,9623,4884,2684,3623,3333,9474,1805,2473,8683,3483,4004,9133,3893,0852,9553,9002,8512,2522,0182,9222,4571,3742,1752,2751,9861,0941,067
Operating Income Ratio 0.0310.0330.0290.0370.0360.0340.0330.0430.040.0370.0350.0450.0390.0430.0440.0560.050.0450.0310.0430.0420.0370.0370.0460.0470.0390.0310.0450.0370.0440.0420.0540.0440.0380.0390.0450.0470.0340.0440.0420.0330.0430.0480.0560.0440.0410.0440.060.0440.0450.0450.0570.0450.0390.0360.0490.0460.0280.0430.0440.0410.0250.026
Total Other Income Expenses Net 148287316465796866986817518441,000655-2454,766601327-2535815754059025177551896375666395766227931,471613-758394776073241,276425314762349340257287229343264312281263213222225283-205308292222189185167228
Income Before Tax 7,7778,7297,5779,6368,5417,4687,1839,5818,6517,7617,4239,2136,89112,4848,23810,9839,4068,0515,5177,4287,6526,2166,0867,1857,6076,0534,6736,8345,4866,2866,5527,4135,1515,1104,6325,6035,2874,7634,6944,6764,0954,2974,5205,5044,1553,5773,7435,1773,7013,3663,2184,1133,0732,4772,3012,7172,7651,6662,3972,4642,1711,2611,295
Income Before Tax Ratio 0.0310.0370.0320.040.0390.0370.0360.0460.0440.0410.0410.0490.0370.070.0470.0580.0490.0480.0340.0450.0480.0410.0420.0470.0520.0430.0350.0490.0420.0510.0540.0590.0430.0460.0440.0510.050.0470.0490.0450.0410.0470.0520.0590.0470.0440.0480.0630.0490.0490.0490.060.0480.0430.0410.0460.0510.0330.0480.0480.0450.0280.031
Income Tax Expense 6812,9592,4973,1281,0272,4832,3663,0991,9502,5522,4212,9691,3153,9752,6573,4922,2102,5831,7952,3791,6752,0131,9662,3001,8481,9601,5312,195-1492,3892,4832,7991,9182,0461,8652,2321,7511,9622,0501,9621,5811,8811,9712,3821,8751,5531,6192,2081,6541,6681,4711,8681,3531,1561,0681,2531,3247611,0841,1091,003588602
Net Income 7,0975,7705,0796,5087,5144,9844,8186,4816,7005,2105,0026,2435,5758,5095,5827,4907,1965,4683,7225,0495,9784,2024,1204,8855,7594,0933,1434,6385,6363,8964,0694,6143,2333,0652,7673,3703,5362,8012,6432,7142,5132,4162,5503,1212,2792,0252,1242,9682,0481,6981,7472,2441,7191,3201,2331,4641,4419051,3121,3541,168672692
Net Income Ratio 0.0280.0240.0220.0270.0340.0250.0240.0310.0340.0280.0280.0330.030.0480.0320.040.0380.0330.0230.0310.0370.0280.0280.0320.0390.0290.0240.0330.0430.0320.0340.0360.0270.0280.0260.0310.0340.0280.0270.0260.0250.0260.0290.0330.0260.0250.0270.0360.0270.0250.0270.0330.0270.0230.0220.0250.0270.0180.0260.0260.0240.0150.017
EPS 179.13145.6128.2164.35189.75125.86121.67163.68169.2131.57126.31157.68140.79214.88140.96189.15181.72138.0893.99127.53150.96106.11104.04123.37145.43103.3679.37117.15142.3398.39102.75116.5481.6477.469.8885.1289.2970.7366.7468.5563.4661.0164.3978.8357.5551.1453.6474.9751.7242.8844.1256.6943.4133.3531.1436.9936.3923.4233.1334.1929.4916.817.3
EPS Diluted 179.13145.6128.2164.35189.75125.86121.67163.67169.2131.57126.31157.68140.79214.88140.96189.15181.72138.0893.99127.53150.96106.11104.04123.37145.43103.3679.37117.15142.3398.39102.75116.5481.6477.469.8885.1289.2970.7366.7468.5563.4661.0164.3978.8357.5551.1453.6474.9751.7242.8844.1256.6943.4133.3531.1436.9936.3923.4233.1334.1929.4916.817.3
EBITDA 13,18612,9947,6659,7158,7107,5057,2849,6368,7737,6207,2089,3127,9918,3298,34611,27910,4538,1075,5977,5477,6276,2075,9657,5707,6266,0834,7536,8795,5066,0925,7807,3115,7834,7854,6885,5245,4184,2204,7174,7273,7564,3454,6035,5384,2103,6243,7745,2353,7983,3863,2754,1383,8523,1222,8873,6843,3382,1872,8952,9122,7181,6281,333
EBITDA Ratio 0.0530.0540.0330.040.0390.0370.0370.0470.0450.0410.040.0490.0430.0470.0480.060.0550.0480.0350.0460.0470.0410.0410.0490.0520.0430.0360.050.0420.0490.0480.0580.0480.0430.0440.050.0510.0410.0490.0450.0380.0470.0530.0590.0480.0450.0490.0640.050.0490.050.060.0610.0540.0510.0620.0620.0440.0580.0560.0560.0370.032